Drug Type Small molecule drug |
Synonyms TY-0540, TYK 00540, TYK-00540 + [1] |
Target |
Mechanism CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors), CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization TYK Medicines, Inc.Startup |
Active Organization TYK Medicines, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Malignant Solid Neoplasm | Phase 1 | CN | TYK Medicines, Inc.Startup | 02 Jan 2024 |
Breast Cancer | IND Approval | CN | TYK Medicines, Inc.Startup | 08 Sep 2023 |
Pancreatic Cancer | IND Approval | CN | TYK Medicines, Inc.Startup | 08 Sep 2023 |
Prostatic Cancer | IND Approval | CN | TYK Medicines, Inc.Startup | 08 Sep 2023 |